PRDM15: A Potential Drug Target Or Biomarker (G63977)

Target Name: PRDM15

NCBI ID: G63977

PRDM15

PRDM15: A Potential Drug Target Or Biomarker

PRDM15 (PRD15_HUMAN), also known as human PR domain-containing protein 15, is a protein that is expressed in various tissues of the human body. It is a key component of the PR domain, which is a family of transmembrane proteins that play a crucial role in cell signaling. PRDM15 has been identified as a potential drug target or biomarker due to its unique structure and the involvement of various diseases, including cancer.

The PR domain is a family of transmembrane proteins that are characterized by the presence of a protein kinase catalytic domain and a nucleotide-binding domain (NBD). The PR domain is involved in various cellular processes, including cell signaling, cell adhesion, and cell survival. PRDM15 is a member of the PR domain family and is expressed in various tissues of the human body, including muscle, heart, brain, and pancreas.

PRDM15 is involved in various cellular signaling pathways, including the TGF-β pathway and the Wnt pathway. The TGF-β pathway is a well-established pathway that is involved in cell signaling and has been implicated in various diseases, including cancer. The Wnt pathway is a signaling pathway that is involved in cell-cell adhesion and has also been implicated in various diseases, including cancer. PRDM15 is involved in both of these pathways and has been implicated in the development and progression of various diseases.

PRDM15 has also been shown to be involved in the regulation of cellular processes that are critical for human health, such as cell growth, apoptosis, and inflammation. It has been shown to play a role in the regulation of cell cycle progression, cell apoptosis, and the production of pro-inflammatory cytokines. These processes are important for the development and progression of various diseases, including cancer.

In addition to its involvement in cellular signaling pathways, PRDM15 has also been shown to be involved in the regulation of gene expression. It has been shown to play a role in the regulation of the expression of various genes, including genes involved in cell adhesion, cell signaling, and inflammation. These genes are important for the development and progression of various diseases, including cancer.

PRDM15 has also been shown to be involved in the regulation of cellular interactions with the immune system. It has been shown to play a role in the regulation of the immune response, including the regulation of T cell function and the production of antibodies. These processes are important for the development and progression of various diseases, including cancer.

In conclusion, PRDM15 is a protein that is involved in various cellular signaling pathways and has been implicated in the development and progression of various diseases. Its unique structure and involvement in multiple cellular processes make it a potential drug target or biomarker. Further research is needed to fully understand the role of PRDM15 in human health and disease.

Protein Name: PR/SET Domain 15

Functions: Sequence-specific DNA-binding transcriptional regulator. Plays a role as a molecular node in a transcriptional network regulating embryonic development and cell fate decision. Stimulates the expression of upstream key transcriptional activators and repressors of the Wnt/beta-catenin and MAPK/ERK pathways, respectively, that are essential for naive pluripotency and self-renewal maintenance of embryonic stem cells (ESCs). Specifically promotes SPRY1 and RSPO1 transcription activation through recognition and direct binding of a specific DNA sequence in their promoter regions. Involved in early embryo development (By similarity). Also plays a role in induced pluripotent stem cells (iPSCs) reprogramming (PubMed:28740264)

The "PRDM15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRDM15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets